19th Conference of the International Society of Geriatric Oncology

Integrative oncology – Leaving no one behind / GENEVA Switzerland 14-16 Nov 2019

  • November 14, 2019 Thursday
  • November 15, 2019 Friday
  • November 16, 2019 Saturday

November 14, 2019 / Thursday

10:00 - 13:00 IFA - SIOG Summit 2019 
Global Policy Dialogue on Cancer in the Ageing Population  
Venue: Palais des Nations, Building E, Door E-40, Room XXIV.
(Separate registration is required for this meeting.
Please click HERE to register IFA - SIOG Summit 2019)
19:00 - 21:00

SIOG 2019 Conference
Poster welcome reception
(to be held in CICG exhibition area)

With the support of    Logo etat de Geneve


November 15, 2019 / Friday

  Registration
08:20 - 08:30

Opening Remarks

Hans Wildiers, SIOG president

08:30 - 09:30

Overview of the year
Chairs: Tanya Wildes, Melisa Wong

News in oncology, Ravindran Kanesvaran
News in geriatrics, Marije Hamaker
Best of JGO, journal of geriatric oncology, Supriya Mohile & Siri Rostoft

09:30 - 10:30

Short oral abstract presentations
Chairs: Heidi Klepin, Kah Poh (Melissa) Loh

O01 Outcomes that matter to patients? The Geriatric Oncology Surgical Assessment and Functional rEcovery after surgery (GOSAFE) study: subgroup analysis of 440 patients undergoing colorectal cancer surgery, Nicole Marie Saur
O02 Crafting age friendly cancer care: A model for improvement utilizing the 4 Ms framework across the continuum of an NCI designated cancer center, Cassandra Vonnes
O03 Assessment of the external validity of the NCCN guidelines for pancreatic ductal adenocarcinoma (PDAC) in a real population of elderly patients aged 70 years and older, Maria Grazia Rodriquenz
O04 Impact of the external validity of the national comprehensive cancer network and European Society for Medical Oncology guidelines for NSCLC on treatment outcomes in a population of patients aged 80 years and older, Nicolò Matteo Luca Battisti
O05 Factors affecting radiotherapy utilisation in geriatric oncology patients in New South Wales, Australia, Penny L Mackenzie
O06 Predictive power of Comprehensive Geriatric Assessment questionnaires to estimate the risk of early death in elderly cancer patients using Machine Learning, Gabrielle Ribeiro Sena
O07 Serious adverse events among older patients in the ALTTO trial, Lissandra Dal Lago
O08 Prostate cancer treatment and the risk of septicemia, Nikita Nikita
O09 Combination of G8 screening tool and hand-grip strength to predict overall survival in patients with non-small cell lung cancer treated with stereotactic body radiotherapy, Kristian Kirkelund Bentsen
O10 Association between frailty and long-term homecare utilization in older adults following cancer surgery: a population-based retrospective cohort study, Tyler R Chesney
O11 Understanding factors influencing outcomes in older rural breast cancer patients, Kelly Kenzik
O12 Obesity paradox in older cancer patients for middle and long-term mortality: a large prospective multicentre cohort study of 2071 patients, Claudia Martinez Tapia
O13 Association of LIPI score with immunotherapy outcomes in elderly population, Capucine Baldini
O14 The prevalence of luminal B subtype is higher in older postmenopausal women with ER+/HER2- breast cancer and is associated with inferior outcomes, Matthew N. Mills
O15 Cytoplasmic cyclin E: an exquisite marker of tumour biology in older women with primary breast cancer, Ruth Mary Parks

10:30 - 11:00  Coffee break & Poster viewing
11:00 - 12:00

The many faces of geriatric assessment

Chairs: Holly Holmes, Christopher Steer

Acute oncology - Geriatric assessment in the emergency department, Thierry Chevalley
Polypharmacy or mobility assessment in patients with haematological malignancies, Tanya Wildes
Geriatric assessment guided interventions - The role of occupational therapy and allied health, Mackenzi Pergolotti

12:00 - 13:00

Breast Cancer MDT

Chairs: Enrique Soto Perez de Celis, Kwok-Leung Cheung

 

Case Presentation 1: HER2+ early breast cancer 

Case Presentation 2: Triple negative early breast cancer

Panelists: Hans Wildiers, Richard Simcock, Ruth Parks, Nicolò Matteo Luca Battisti

13:00 - 14:30  Break for lunch
14:30 - 15:30

Colorectal cancer MDT
Chair: Ponnandai Somasundar

Case 1: rectal cancer

Panelists: Siri Rostoft, Nicole Saur, Athanasios Karampeazis, Isacco Montroni, Amy MacKenzie

15:30 - 16:30 SIOG General assembly
16:30 - 17:00  Coffee break & Poster viewing & Young SIOG poster discussion
17:00 - 18:30

Special symposium: 
Research for older patients: all-out development from humanities to trials,

by CARG, EORTC and INCa  

Chairs: Stuart Lichtman, Etienne Brain

Political commitment, Jérôme Foucaud
Barriers to participation, Florence Canoui Poitrine
TBA, Myriam Pannard
Clinical trial eligibility and ASCO act, Stuart Lichtman
Composite/co-primary endpoints and challenges in statistics at EORTC, Antonella Brunello
Epidemiological research and others CARG actions, Supriya Mohile & William Dale
Pharmacology monitoring and DDI, Ginah Nightingale
Asian perspective: the JCOG initiative, Tomonori Mizutani
Discussion

18:30 - 19:30 Research on geriatric evaluation symposium

(Joint symposium with Young SIOG, Nursing/Allied Health, EUGMS)

Chairs: Martine Puts (NAH), Gabor Liposits (young SIOG), Claire Falandry (EUGSM)

 

Impact of geriatric assessment on survival, function, and nutritional status in older patients with head and neck cancer: preliminary results of the EGeSOR randomized multicenter controlled trial, Florence Canoui Poitrine

Geriatric comanagement is associated with reduced 90day postoperative mortality among patients aged 75+ with cancer, Soo Jung Kim

Prehabilitation in preoperative care of prehab as medicine, Barbara van Munster

20:00 - 22:30

Networking event
(Ticket event, venue to be announced)


November 16, 2019 / Saturday

07:00 - 08:30

Geriatric evaluation workshop

A separate registration is required for this workshop due to limited capacity.

Chairs: Cindy Kenis (NAH), Melissa Loh (young SIOG)

1) Geriatric screening tools (VES-13, Geriatric 8), Gábor Liposits, Cindy Kenis
2) Cognitive assessments (MOCA, MMSE, Mini-Cog), Allison Magnuson, Martine Puts
3) Physical Performance Batteries (SPPB, TUG, gait speed, etc.), Mackenzi Pergolotti, Schroder Sattar
4) Chemotherapy toxicity calculators (CARG, CRASH, MAX2), Nicolò Matteo Luca Battisti, Melisa Wong
5) Life expectancy calculators, Enrique Soto Perez de Celis, Nina Rosa Neuendorff
6) Social support and psychological health, Kristen Haase, Fábio Gomes
7) Medications and polypharmacy, Erika Ramsdale, Ginah Nightingale

08:30 - 09:30

Lung cancer MDT
Chair: Ishwaria Subbiah

Case 1: stage IIIa lung cancer.
Case 2a: metastatic disease with good PS
Case 2b: metastatic disease with poor PS

Panelists: Michael T. Jaklitsch, Holly Holmes, Lore Decoster, Fabio Gomes

09:30 - 10:30

Short oral abstract presentations

Chairs: William Dale, Nina Rosa Neuendorff

O16 Functional capacity and levels of physical activity as risk factors for hospitalization in elderly cancer patients: prospective cohort, Jurema T O L Sales
O17 Functional recovery in older women undergoing surgery for gynaecological malignancies: a systematic review and narrative synthesis, Fionna E Martin
O18 Fatigue is independently associated with functional status limitations in older adults with cancer – results from the cancer and aging resilience evaluation (CARE) registry, Grant R Williams
O19 Decline in physical function (PF) is associated with pretreatment depressive symptoms, decreased mobility, more pain, and dyspnea in older cancer patients referred for systemic cancer treatment, Magnus Harneshaug
O20 Stepping on: Cancer edition changes behaviors and improves balance in older adults with cancer and their caregivers, Tanya M Wildes
O21 Risk factors for falls in older persons with cancer: a multicenter study, Jessie De Cock
O22 The high impact of preoperative social frailty on overall survival in elderly gastrointestinal cancer patients, Rei Ono
O23 Implementation of a clinical frailty pathway at a cancer centre – a quality improvement project, Fabio Gomes
O24 Geriatric and oncological predictors of survival and chemotherapy toxicities in elderly patients with metastatic non small cell lung cancer: an analysis of ESOGIA trial, Florence Canouï Poitrine
O25 Cancer-specific mortality and competing causes of death in older adults: a prospective multicenter cohort study (ELCAPA 19), Deborah Assouan
O26 Depressive symptom profiles and survival in older patients with cancer: latent class analysis of the ELCAPA cohort study, Florence Canouï Poitrine
O27 Discussing older patients during oncological multidisciplinary team meetings; is there a difference compared to younger patients? Suzanne Festen
O28 Patient-defined preferences and health outcome prioritization among older adults with cancer starting chemotherapy, Enrique Soto Perez De Celis
O29 “I have a doctor that handles all the other stuff.” Perceptions of older adults about discussing age-related conditions with their oncologists: A university of Rochester NCI community oncology research program (NCORP) geriatric assessment (GA) trial, Sindhuja Kadambi
O30 Guided geriatric interventions (GI) in older adults with cancer: What, how, and for whom? The French PACA EST Cohort Experience, Rabia Boulahssass

10:30 - 11:00  Coffee break & Poster viewing
11:00 - 12:00

Hematology MDT

Chair: Vicki Morrison

 

Case 1: AML

Case 2: Non Hodgkins Lymphoma

Panelists: Melissa Loh, Heidi Klepin, Reinhard Stauder, Konstantinos Christofyllakis, Raul Cordoba, Noam Vanderwalde

12:00 - 13:00

Keynote oral abstract presentations

Chairs: Siri Rostoft, William P. Tew

KO1 Patient Reported Outcomes Measures (PROMs) in geriatric patients undergoing major surgery for solid cancer. 90-day preliminary report on 643 patients from the Geriatric Oncology Surgical Assessment and Functional rEcovery after Surgery (GOSAFE) study, Isacco Montroni
KO2 Optimizing chemotherapy for frail and/ or elderly patients with advanced gastroesophageal cancer (aGOAC): The GO2 phase III trial, Daniel Edmund Bryan Swinson
KO3 Predicting life expectancy in older adults with advanced cancer: An evaluation of oncologists’ estimates and a geriatric assessment-based predictive model, Jennifer L Lund
KO4 Prognostic value of inflammation-based routine biomarkers in older patients with cancer: pooled analysis of three prospective cohorts, Nadia Oubaya
KO5 Cost effectiveness of a geriatric oncology clinic, Zuhair Alam

13:00- 14:30  Break for lunch
14:30 - 15:30

Prostate cancer MDT
Chair: Shane O’Hanlon

Case 1: localised prostate cancer
Case 2: metastatic prostate cancer

Panelists: Lucinda Morris, Antonella Brunello, Cecilia Lund, Patrice Jichlinski

15:30 - 16:30 Presidential session
16:30 - 17:00  Coffee break & Poster viewing
17:00 - 18:30

Debate session: Controversial issues in geriatric oncology

Chairs: Martine Extermann, Kwok-Leung Cheung, Enrique Soto Perez de Celis

Debate 1: Can chemotherapy toxicity calculators be used across diseases and settings?
Discussing arguments FOR: Allison Magnuson / AGAINST: Erin Moth

Debate 2: Breast and colorectal cancer screening in older adults.
Discussing arguments FOR: Lodovico Balducci/ AGAINST: Shabbir Alibhai